Of note, we previously reported HER2 expression being highly unstable during disease evolution from primary breast cancer to relapse, mainly due to HER2-low-positive cases switching either from or to HER2-0 expression and findings from the present work solidify the great instability of HER2-low-positive expression in a different setting. Here, ERBB2 is linked to breast cancer.